Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/07/2010CA2427560C Alkynyl amides and their therapeutic applications
12/07/2010CA2421114C 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2375968C Imaging the dopamine transporter to determine ad-hd
12/07/2010CA2368850C Methods for the prevention and/or the treatment of glutamate cytotoxicity
12/07/2010CA2328345C Process for the production of r-(+)-6-carboxamido-3-n-methylamino-1,2,3,4-tetrahydrocarbazole
12/07/2010CA2285516C Dopamine transporter imaging agents
12/02/2010WO2010138833A1 SUBSTITUTED IMIDAZO[1,5-a]QUINOXALINES AS INHIBITORS OF PHOSPHODIESTERASE 10
12/02/2010WO2010138600A2 Pharmaceutical compositions for the treatment of pain
12/02/2010WO2010138589A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010137890A2 Composition for improving the viability and proliferation ability of stem cells
12/02/2010WO2010137738A1 Heterocyclic compounds for the treatment of stress-related conditions
12/02/2010WO2010137696A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
12/02/2010WO2010137689A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137547A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010137022A1 Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
12/02/2010WO2010137018A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
12/02/2010WO2010136964A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
12/02/2010WO2010136803A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010WO2010136621A1 Use of rgs-14 protein in order to produce a drug for the treatment or prevention of cognitive and memory disorders
12/02/2010WO2010136546A1 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
12/02/2010WO2010136487A1 Albumin-amyloid peptide conjugates and uses thereof
12/02/2010WO2010135798A1 Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains; pharmaceutical composition containing telocinobufagin and its use
12/02/2010WO2010120695A3 5-ht4 receptor agonist compounds for treatment of cognitive disorders
12/02/2010WO2010116386A3 Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
12/02/2010WO2010115741A3 New therapeutic approaches for treating neuroinflammatory conditions
12/02/2010WO2010083384A3 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/02/2010WO2010080970A3 Oral enteric antidepressant formulation
12/02/2010WO2010057295A9 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
12/02/2010WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305212 Therapeutic compounds
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305187 Methods and compounds for treating diseases caused by reactive oxygen species
12/02/2010US20100305183 Method and composition for reducing reperfusion injury
12/02/2010US20100305181 Methods for treating a variety of diseases and conditions, and compounds useful therefor
12/02/2010US20100305166 Novel compounds
12/02/2010US20100305162 Methods for the Synthesis of Pyridoxamine
12/02/2010US20100305159 Crystalline form of piperidine compound
12/02/2010US20100305157 derivatives of dicarboxylic amino acids and their application in the treatment of neurodegenerative diseases
12/02/2010US20100305150 Tuberous sclerosis treatment
12/02/2010US20100305141 Tetrahydroindolone derivatives for treatment of neurological conditions
12/02/2010US20100305135 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305130 Nasal spray device and method of use thereof
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305109 Potassium channel modulators
12/02/2010US20100305108 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305103 Genes differentially expressed in bipolar disorder and/or schizophrenia
12/02/2010US20100305102 Heterocycle-substituted piperazino-dihydrothienopyrimidines
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305091 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305059 Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100305037 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303934 Methods and compositions for nerve regeneration
12/02/2010US20100303924 Process for Producing A Beverage Comprising Cocoa Material with Enhanced Polyphenol Levels
12/02/2010US20100303906 Solid dosage forms of valsartan and amlodipine and method of making same
12/02/2010US20100303905 Orally Disintegrating Tablet Compositions of Lamotrigine
12/02/2010US20100303903 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010US20100303900 Preparation of injectable suspensions having improved injectability
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303887 DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
12/02/2010US20100303881 Therapeutic Electrospun Fiber Compositions
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303840 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
12/02/2010US20100303824 Signaling intermediates in an in vitro model of alzheimer's disease
12/02/2010US20100303805 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/02/2010US20100303792 Protein synthesis required for long-term memory is induced by pkc activation on days preceding associative learning
12/02/2010US20100303787 Methods of Treating Urogenital-Neurological Disorders Using Galanin Retargeted Endopepidases
12/02/2010US20100303785 Novel therapeutics based on tau/microtubule dynamics
12/02/2010US20100303784 Preparation for the prevention and/or treatment of vascular disorders
12/02/2010US20100303782 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
12/02/2010US20100303771 Gaba neuron progenitor cell marker 65b13
12/02/2010US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses
12/02/2010US20100303741 Wolfberries and inflammation
12/02/2010US20100303716 Switchable nano-vehicle delivery systems, and methods for making and using them
12/02/2010DE102007033359B4 Verwendung eines Granulins oder einer Granulin-ähnlichen Verbindung zur Therapie oder Prophylaxe von chronischen Schmerzen Use of a granulin or granulin-like compound for the treatment or prophylaxis of chronic pain
12/02/2010CA2763569A1 Albumin-amyloid peptide conjugates and uses thereof
12/02/2010CA2763320A1 Oral medical composition and oral medical capsule enclosing the same
12/02/2010CA2763172A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2762528A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 1833